Ifp Advisors, Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Ifp Advisors, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$7.0 - $16.87 $28 - $67	-4 Reduced 80.0%	1 $1,000
Q2 2022 Sep 06, 2022	BUY	$83.14 - $145.99 $415 - $729	5 New	5 $2,000
Q2 2022 Aug 12, 2022	SELL	$83.14 - $145.99 $415 - $729	-5 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$110.08 - $142.92 $550 - $714	5 New	5 $0
Q3 2021 Oct 06, 2021	SELL	$98.85 - $138.91 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$65.78 - $105.02 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	SELL	$64.07 - $91.75 $1,793 - $2,569	-28 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$29.01 - $74.23 $812 - $2,078	28 New	28 $2,000
Q1 2019 May 15, 2019	SELL	$34.52 - $53.29 $414 - $639	-12 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$23.54 - $38.21 $282 - $458	12	12 $0

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.